4816

GVK Bio collaborates with Endo Pharma for drug discovery

GVK Bio will use drug discovery expertise to deliver clinical candidate, while Endo will develop, commercialize the product
Comment E-mail Print Share
First Published: Mon, Jan 28 2013. 01 47 PM IST
For GVK, the collaboration is also part of its newly initiated early discovery assets business. Photo: Pradeep Gaur/Mint
For GVK, the collaboration is also part of its newly initiated early discovery assets business. Photo: Pradeep Gaur/Mint
Mumbai: GVK Biosciences Pvt. Ltd, a Hyderabad-based contract research firm, said on Monday it has signed a collaboration agreement with Endo Pharmaceuticals Inc. of the US for discovering novel small molecules targeting a unique protein.
GVK Bio will use its drug discovery expertise to deliver a clinical candidate and Endo will develop and commercialize the product.
For GVK, the collaboration is also part of its newly initiated early discovery assets (EDA) business. “This collaboration confirms the value of our differentiated EDA concept, conceived to collaborate with pharmaceutical partners on discovery projects, from target to clinical candidates,” Manni Kantipudi, chief executive officer of GVK Bio, said in a release on Monday.
Comment E-mail Print Share
First Published: Mon, Jan 28 2013. 01 47 PM IST
blog comments powered by Disqus
  • Wed, Jul 30 2014. 05 04 PM
  • Wed, Jul 23 2014. 06 06 PM
ALSO READ close

Indian pharmaceutical industry asks govt to incentivise innovation

Subscribe |  Contact Us  |  mint Code  |  Privacy policy  |  Terms of Use  |  Advertising  |  Mint Apps  |  About HT Media  |  Jobs
Contact Us
Copyright © 2014 HT Media All Rights Reserved